The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs
Provides Protection for People with
Lupus and other Chronic Diseases
WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- The
Lupus Foundation of America (LFA) President and Chief Executive Officer, Sandra C. Raymond, issued the following statement regarding S.1630 "The Affordable Acce...
Immune responses to flu vaccine are diminished in lupus patients
Patients with the autoimmune disease systemic
lupus erythematosus (SLE) have an increased risk of infection, due to both disturbances in their immune responses and treatment with immunosuppressive drugs. Because morbidity and mortality related to influenza are increased in immunocompromised patien...
Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus
ROCKVILLE, Maryland July 20 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) will host a conference call today at 8:15 AM Eastern to discuss the results from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA(TM) (belimumab, formerly Ly...
Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The
Lupus Foundation of America (LFA) is seeking proposals for grant funding for research studies on lupus, an unpredictable and potentially fatal autoimmune disease. Grants will support areas of study in pediatric
lupus and adult stem cell transplant...
Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients
Copenhagen, Denmark, Friday 12 June 2009: 92.8% of patients with systemic
lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL), according to the results of a new study presented today at EULAR 2009, the Annual C...
Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
Copenhagen, Denmark, Thursday 11 June 2009: DNA vaccination using
lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in pa...
More>>
Lupus in Medical Technology
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
ROCKVILLE, Maryland and LONDON, July 20 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) met the primary endpoint in BLISS-52, the first of two pivotal P...
Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
WASHINGTON, June 3 /PRNewswire-USNewswire/ -- To foster and support the next generation of
lupus researchers, the
Lupus Foundation of America (LFA), Inc. has awarded summer fellowships to five young investigators who will conduct their studies under the supervision of an established
lupus investig...
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
- Phase 2 data demonstrate sustained improvement in disease activity through three years of LymphoStat-B (belimumab) therapy -
- No increase in adverse events, malignancies, infections or laboratory abnormalities over time -
ROCKVILLE, Md., June 12 /PRNewswire-F...
Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Preliminary results
were released today from a late-stage clinical trial of Rituxan (rituximab)
for the treatment of lupus. The study did not meet its primary or secondary
endpoints of clinically reducing the severity of SLE (systemic lupus
eryth...
Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
Lead drug candidate may help patients with Systemic
Lupus Erythematosus (SLE)
SOUTH SAN FRANCISCO, Calif., April 29 /PRNewswire-FirstCall/ -- Rigel
Pharmaceuticals, Inc. (Nasdaq: RIGL ) announced today that its lead product
candidate, R788, has successfully tre...
Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
CAMBRIDGE, Mass., Jan. 15 /PRNewswire/ -- Tolerx, Inc., a
biopharmaceutical company engaged in the discovery and development of novel
therapies for the treatment of immune-mediated diseases, announced today
the successful completion of a Phase Ib clinical study of TRX1, a novel
humanized anti-...
More>>
Lupus in Medical Products
Systemic Lupus Erythematosus (SLE) Latex Test
Description: Latex agglutination slide test for the qualitative and semi-qualitative detection of antinuclear antibodies to aid in the diagnosis of systemic
lupus erthyematosus....
Company:Inverness Medical Innovations
Bio-Rad Helix EIA Lupus Screening Kit
Description: The ANA and ENA assays can be used to screen out patients negative for antinuclear antibodies, which are associated with various systemic rheumatic diseases such as Systemic
lupus erythematosus (Lupus), Sjgren's syndrome, mixed connective tissue disease, progressive systemic sclerosis, scleroderma,...
Company:Bio-Rad Laboratories
STACLOT LA 10
Description:... Detection of
lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulat...
Company:Diagnostica Stago, Inc.
STACLOT LA 20
Description:... Detection of
lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasma with heparin inhibitor; PTT-LS reagent of cephalin and particula...
Company:Diagnostica Stago, Inc.
ImmunoDOT DNA/ENA Autoimmunity Screening Panel
Description:...of autoantibodies against various specific nuclear antigens (ANA, DNA, SS-A/SS-B, RNP/Sm) in serum, and is used as an aid in the diagnosis of systemic
lupus erythematosus (SLE), mixed connective tissue disease (MCTD), and Sjgren's syndrome....
Company:GenBio
ImmunoDOT Autoimmunity Screening Panel 6
Description:...dies against various specific nuclear antigens (SS-A, SS-B, RNP/Sm, Sm, Jo-1, and Scl-70) in serum, and is used as an aid in the diagnosis of systemic
lupus erythematosus (SLE), mixed connective tissue disease (MCTD), Sjgren's syndrome and other rheumatoid diseases....
Company:GenBio
More>>
Lupus in Medical Definition
Pathology
...• d • e
Health science - Medicine - Urinary system - Pathology - Nephrology ( N00-N39 )
Diseases of the glomerulus
lupus nephritis | Post-infectious glomerulonephritis | Minimal change disease | Focal segmental glomerulosclerosis | Diabetic nephropathy | IgA ne...
Lupus in Medical Dictionary
Lupus
Systemic
lupus erythematosus is a chronic autoimmune connective tissue disease that can affect any part of the body. As occurs in other autoimmune diseases, the immune system attacks the body’s cells and tissue, resulting in... Get information on
lupus (SLE) disease treatment, sig...
Vasculitis
...iew covers symptoms, causes, treatment of this inflammation of the blood vessels. ... Hypersensitivity vasculitis . ... This section of the
lupus Foundation of America's website talks about vasculitis , and lupus. ... This cause of vasculitis is more common. ... Cutaneous vasculitis . Au...
Turner syndrome
...... Genetic Features of Turner Syndrome (National Institute of Child ... Article: 46,X,del(X)(q13) Turner's syndrome women with systemic
lupus erythematosus in a... In Turner syndrome , cells are missing all or part of an X chromosome. ... Growth hormone may help a child with Turne...
Systemic sclerosis
...ma. U.-F. Haustein, MD. Dermatology Online ... Systemic sclerosis (SSc) is a clinically heterogeneous generalized disorder ... ... systemic
lupus erythematosus and scleroderma (also known as systemic sclerosis ) ... Because systemic sclerosis patients do not always tolerate conventiona...
Systemic lupus erythematosus
... Systemic
lupus erythematosus is a chronic autoimmune connect...nd tissue, resulting in... Get information on
lupus (SLE) disease treatment, signs, diagnosis, type...egnancy flares, prevention and statistics.
lupus , discoid on a child's face. Systemic ...
Systemic
...rror in measurements or... Get information on
lupus (SLE) disease treatment, signs, diagnosis, type... systemic infection. ... Find information on
lupus ( systemic
lupus erythematosus, or SLE). Covers symptoms, tests, t...
Lupus in Biological News
Gene linked to lupus might explain gender difference in disease risk
DALLAS March 30, 2009 In an international human genetic study, researchers at UT Southwestern Medical Center have identified a gene linked to the autoimmune disease lupus, and its location on the X chromosome might help explain why females are 10 times more susceptible to the disease than males....
The Alliance for Lupus Research announces 2008 grantees
The Alliance for
Lupus Research (ALR) recently announced it will award nearly $7 million to researchers around the world. The ALR is very proud to announce, during National Minority Health Month, that with our 2008 class of grantees the ALR has funded more than 100 research projects, and committe...
Genes linked with lupus are revealed, giving hope for new treatments
Scientists have identified a number of genes involved in Lupus, a devastating autoimmune disease, in new research published today in the journal Nature Genetics.
In an international genetic study of more than 3,000 women, researchers found evidence of an association between
Lupus (systemic lupu...
DNA variations signal lupus risk
BIRMINGHAM, Ala. Scientists have pinpointed a set of common variations in human DNA that signal a higher risk for
lupus in women who carry them. Some of these variations are more common in relatives of
lupus patients, which may help future studies examining whether
lupus is more prevalent among c...
UT Southwestern secures $5 million NIH grant for lupus research
DALLAS Dec. 19, 2007 The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million grant from the National Institutes of Health to fund the Center of Research Translation, which will investigate the autoimmune...
New approach for attacking lupus identified
NEW YORK CITY, Dec. 16, 2007 Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus. If companies are able to develop drugs that hone in on these targets, patients may be able to control their disease with few side effects.
The study ...
Lupus in Biological Technology
Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA(TM) (belimumab, formerly LymphoSta...
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
- Phase 2 continuation data demonstrated sustained improvement in disease activity and patient response rate through four years of BENLYSTA therapy -
- Frequency of disease flares as measured by the SELENA SLEDAI flare index and by BILAG A or B organ domain scores decreased over four years o...
Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
SEATTLE, March 25 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) announced today that its collaboration partner Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has initiated a Phase 1 clinical trial of SBI-087, Trubion's next generation CD20 drug candidate, fo...
Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9
Animal Model Shows Disease Progression Can Be Prevented
BERKELEY, Calif., Nov. 26 /PRNewswire-FirstCall/ -- In a paper
appearing online in the December issue of The European Journal of
Immunology (Vol. 37, Issue 12), Dynavax scientists report the results of
studies made possible under ...
ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
- Patient enrollment to begin in fourth quarter -
SEATTLE, Oct. 4 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq:
ZGEN) today announced that, together with its collaborator Merck Serono, it
has reached agreement with the U.S. Food and Drug Administration (FDA) on a
Special Pro...
Biotech Hot in July Driven by Positive Drug Data and Acquisitions
...el investors' enthusiasm was Human Genome Sciences whose shares jumped a whopping 395 percent in July on news of positive results for its experimental
lupus injectable drug Benlysta, confounding all analysts' expectations and potentially clearing the way for the first new treatment against the inflammatory...
Lupus in Biological Products
Total Protein - Alzheimer's Disease: Brain: Pons from BioChain
Description:... Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and
lupus diseased tissues are available....
Company:BioChain
Total Protein - Diabetic Disease: Small Intestine: Jejunum from BioChain
Description:... Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and
lupus diseased tissues are available....
Company:BioChain
Total Protein - Diabetic Disease: Esophagus from BioChain
Description:... Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and
lupus diseased tissues are available....
Company:BioChain
Membrane Protein - Alzheimer's Disease:Brain: Occipital Lobe from BioChain
Description:... Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and
lupus diseased tissues are available....
Company:BioChain
Lupus in Biological Definition
Apoptosis
...amental factor in the pathogenesis of numerous diseases including cancer, neuro-degenerative and ischemic diseases, AIDS and autoimmunity. In systemic
lupus erythematosus (SLE) the antigen responsible for most anti-DNA antibodies, exclusively generated in this disease, are derived from nucleosomes. As nucl...
Immune system
...ns .
On the other end of the scale, an overactive immune system figures in a number of other disorders, particularly autoimmune disorders such as
lupus erythematosus , type I diabetes (sometimes called "juvenile onset diabetes"), multiple sclerosis , psoriasis , and rheumatoid arthritis . In thes...
Immunology
...examples include chronic granulomatous disease ), and autoimmunity , in which the immune system attacks its own antigens (examples include systemic
lupus erythematosus , rheumatoid arthritis , Hashimoto's disease and myasthenia gravis ). Other immune system disorders include different hypersensitiv...
Kidney
....
kidney tumors
Wilms tumor
Renal cell carcinoma
Renal failure (acute and chronic)
Glomerulonephritis
Diabetic nephropathy
lupus nephritis
Dialysis and kidney transplants
Generally, one can live fine with just one kidney. If both kidneys do not function properly, dialy...
Lupus in Biological Dictionary
Serosa
...aced by adventitia a layer ... The serosa reduces friction as the digestive system organs work and slide across ... Clinical overview of Systemic
lupus Erythematosus (SLE), a chronic, ... the joints, skin, kidney, brain, lung, heart, serosa and gastrointestinal tract. ... ... the internal reprodu...
Pericardium
...ew articles on Diseases of the pericardium ... Ongoing Trials on Diseases of the pericardium at Clinical Trials.gov ... pericardium . systemic
lupus erythematosus ... Chest x-rays may detect calcium deposits in the pericardium . ... Normally, the pericardium is less than 1/8 inch ... Chest x-...
Cooperativity
...ty ... Search completed in 0.299 seconds. ... Cooperativity of APRIL with BLyS Protein: BLyS protein is a 285-amino acid member of ... Systemic
lupus Erythematosus: Cooperativity of APRIL with BLyS ... Cooperativity in contractile behavior of ... It is widely held that there is cooperativity...